For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study that is expected to change the way such patients are treated. The report was one of several highly anticipated studies on immunotherapy and lung cancer presented Monday […]Related:This 3-year-old has ‘a sparkle’ in her heart: The world’s smallest mechanical heart valveFDA restricts sale of Essure contraceptive device, requires that women be informed of risksWith $2 million, Kaiser Permanente wants to help revive underfunded gun-violence research
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news